[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letters
February 26, 1997

Smoking and Risk of Cryptococcosis in Patients With AIDS

Author Affiliations

Naval Medical Center San Diego, Calif

JAMA. 1997;277(8):629-630. doi:10.1001/jama.1997.03540320031029
Abstract

To the Editor.  —Disseminated Cryptococcus neoformans infection (DCI) is the most common invasive fungal disease and the third most common central nervous system disorder in patients with human immunodeficiency virus (HIV) infection.1 In the United States, as many as 40% of patients with CD4+ cell counts less than 0.10×109/L may be receiving primary antifungal prophylaxis. Because acquisition of infection is by the aerosol route, we questioned the possible association of cryptococcal disease with smoking.As part of the standard HIV evaluation at the Naval Medical Center, San Diego, Calif, patient smoking history is documented routinely. We retrospectively reviewed records of HIV-infected individuals who had CD4+ lymphocyte counts less than 0.10×109

×